Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

81 results about "Prostate disease" patented technology

The three most common forms of prostate disease are inflammation (prostatitis), non-cancerous enlargement of the prostate (benign prostatic hyperplasia, or BPH) and prostate cancer. A man may experience one or more of these conditions.

Umbilical cord mesenchymal stem cell preparation and application thereof in treatment of prostate diseases

The invention belongs to the technical field of biological medicines, and particularly relates to an umbilical cord mesenchymal stem cell preparation and application thereof in treating prostate diseases. According to the umbilical cord mesenchymal stem cell preparation, the umbilical cord mesenchymal stem cells of the third generation to the sixth generation and the neurofilament peptide serve as active components, pharmaceutically acceptable auxiliary materials are matched, the prostate index can be remarkably reduced, the concentration of PACP and SRD5A2 can be reduced, and the umbilical cord mesenchymal stem cell preparation has a remarkable curative effect on prostatic hyperplasia. And the umbilical cord mesenchymal stem cells of the third generation to the sixth generation and the neurofilament peptide supplement each other and have a synergistic effect, so that a remarkable progress is generated.
Owner:ZHONGYOU ZHENGUO (ZHEJIANG) TECHNOLOGY DEVELOPMENT CO LTD

Non-invasive predictive kit and method for the progression of benign prostatic hyperplasia based on prostatic fluid.

This invention relates to a non-invasive predictive kit and method for the progression of benign prostatic hyperplasia (BPH) based on prostatic fluid. The invention provides the application of FGF9 as a non-invasive predictive biomarker for the progression of BPH based on prostatic fluid, wherein the concentration of FGF9 in prostatic fluid serves as an indicator of BPH progression. The invention also provides a method for detecting the concentration of FGF9 in prostatic fluid for non-disease diagnostic purposes. Compared with existing technologies, the non-invasive BPH detection method based on prostatic fluid of this invention has advantages such as non-invasiveness, accuracy, simplicity, practicality, and scalability, and is expected to be widely used in the clinical diagnosis and treatment of prostate diseases.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Dry, comfortable, antibacterial and itching-relieving protection pad and preparation method thereof

The invention discloses a dry, comfortable, antibacterial and itching-relieving protection pad. The protection pad is formed by compounding a base layer and a surface layer, and the base layer is a non-woven fabric layer; and the surface layer is a medicine-carrying composite non-woven fabric layer. The protection pad surface layer is located above the base layer, the area of the protection pad surface layer is smaller than that of the base layer, and active ingredients extracted from radix sophorae flavescentis, cortex phellodendri, radix stemonae, cortex dictamni and golden larch bark and an antibacterial material polyhexamethylene biguanide are introduced into the skin-attaching non-woven fabric of the protection pad surface layer, so that the protection pad has the effects of resisting bacteria, relieving itching, clearing damp, expelling parasites and the like; the disposable disposable diaper is suitable for anorectal postoperative wound repair, prostate disease urine leakage, obesity and hidrosis and other field operation people, is particularly beneficial to tinea corporis and rotten crotch in special occasions, and has a good application prospect. The invention further discloses a preparation method of the protection pad.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Bionic electric sensor, preparation method thereof and application of bionic electric sensor in ultrasensitive detection of sarcosine

The invention belongs to the technical field of sarcosine detection, and provides a bionic electric sensor, a preparation method thereof and application of the bionic electric sensor in ultrasensitive detection of sarcosine. The method comprises the following steps: mixing a red blood cell solution and a bionic active substance, and carrying out co-incubation to obtain bionic red blood cells, and mixing the bionic red blood cells with a conductive polymer (dopamine, pyrrole, aniline or thiophene), and carrying out an in-situ polymerization reaction to obtain the bionic electric sensor. The conductive polymer is combined with natural cells, the excellent conductivity of the conductive polymer is utilized, and meanwhile, based on the high-oxygen microenvironment of the cells, the bionic active substance has better electrocatalytic property and can be used for rapid, sensitive and efficient monitoring of Sar. The bionic electric sensor has the advantages of being high in reaction speed, low in cost, easy to miniaturize, good in biocompatibility, simple in sample pretreatment and the like, and a novel, rapid, accurate and stable diagnostic tool can be provided for the morbidity and development law of prostate diseases.
Owner:XINXIANG MEDICAL UNIV

Solabegron zwitterion and uses thereof

This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
Owner:B3AR THERAPEUTICS INC

Balloon assembly for dosing prostate

The utility model provides a balloon assembly for dosing prostate, which comprises a balloon catheter, a positioning balloon fixedly arranged at the far end of the balloon catheter, and an olive-shaped balloon adjacent to the positioning balloon and fixedly arranged on the balloon catheter, a pharmaceutical composition layer is arranged on the outer surface of the olive-shaped balloon, and the positioning balloon is fixedly arranged on the balloon catheter. The positioning balloon is used for being arranged in the bladder of a patient and used for positioning the balloon catheter, and the olive-shaped balloon is used for being arranged in the prostate of the patient and used for expanding and dosing the prostate by making contact with the inner wall of the prostate. Wherein the positioning balloon and the olive-shaped balloon are both non-compliant balloons or low-compliant balloons. The balloon assembly is combined with an existing instrument to treat prostate diseases, the narrow urethra of the benign hyperplasia section of the prostate can be safely expanded, restenosis of the urinary tract is reduced, and the purpose that a patient normally urinates is achieved.
Owner:启维医疗技术(深圳)有限责任公司

Mesenchymal stem cell composition for treating prostate disease and preparation method and application thereof

The present application relates to the technical field of stem cell medicine, in particular to a mesenchymal stem cell composition for treating prostate diseases and a preparation method and application thereof. The mesenchymal stem cell composition for treating prostate diseases comprises mesenchymal stem cells treated by low oxygen and an anti-inflammatory peptide WYPWMKKHHRRRRRRRRR. The prostate diseases are selected from prostatitis, prostate calcification, sexual function improvement, frequent urination and urgency, etc. The mesenchymal stem cell composition can significantly improve the symptoms of prostate diseases, and the curative effect is remarkable.
Owner:广州飞来爱生命科技有限公司

Preparation and use of magnetic silicone health care material

PCT designated stage expiredWO2025076844A1Heavy metal active ingredientsElectrotherapySilica gelNursing
The present invention relates to the technical field of health care, and specifically relates to the preparation and use of a magnetic silicone health care material. The magnetic silicone health care material sequentially comprises, from the inside to the outside, a magnetically conductive layer, a silicone magnetic material layer, and a magnetic shielding coating layer. The silicone magnetic material layer consists of a magnetic material, microporous silicone, a traditional Chinese medicine extract, an iron silicide, graphene, and calamine, and can generate a magnetic field and has health care functions; the magnetically conductive layer consists of a hydrogel-graphene composite material, and can enhance the magnetic field according to acupuncture points, improving treatment and health care effects; and the magnetic shielding coating layer contains a magnetic shielding filler, and can prevent an externally applied magnetic field from causing the magnetism of the magnetic material to weaken or disappear. Further provided in the present invention is a preparation method for the magnetic silicone health care material. The prepared magnetic silicone health care material has strong magnetism and good health care effects, is skin-friendly, and has permanent magnetism and is not prone to demagnetization. The magnetic silicone health care material of the present invention can be used in the treatment of alopecia, low back pain, and prostate disease.
Owner:GUO XIJUN

Use of morus alba extract in preparation of drug for treating and / or preventing prostate diseases

PCT designated stageWO2025162470A1AntipyreticAnalgesicsDiseaseMorus alba extract
The use of a Morus alba extract in the preparation of a drug for treating and / or preventing prostate diseases. The Morus alba extract contains an alkaloid with a weight content of 3% or more, and / or a polysaccharide with a weight content of no more than 70%, and / or a flavone with a weight content of no more than 10%, and / or an amino acid with a weight content of no more than 50%, and / or other components. The Morus alba extract has a significant therapeutic effect on prostate-related diseases.
Owner:BEIJING WEHAND BIO PHARMACEUTICAL CO LTD +1

Prostate MRI registration method based on dense convolution and gated feature extraction network

The invention provides a prostate MRI registration method based on dense convolution and a gated feature extraction network, and the method comprises the steps: obtaining a prostate MRI image sequence of each target user, and the MRI image sequence comprises a fixed image and a moving image; preprocessing the fixed image and the moving image; inputting the pre-processed fixed image and the pre-processed moving image into a gating residual fusion module, and respectively extracting coarse features of the fixed image and the moving image through different convolutional networks; the coarse features and the corresponding source images are subjected to slice cross splicing and then input into a registration network, and a deformation field is output; the registration network comprises a dense convolution module and a Swin Transform module; and according to the deformation field, obtaining a registered image through a spatial transformation network. According to the method, the accuracy and efficiency of multi-modal medical image registration are effectively improved, and important technical support is provided for diagnosis and treatment of prostate diseases.
Owner:HAINAN UNIV

Medical biological dressing suppository matrix and preparation method thereof

PendingCN121421935ADigestive systemSuppositories deliveryBiological dressingIrritation
The invention discloses a medical biological dressing suppository matrix and a preparation method thereof, and relates to the technical field of suppositories, the medical biological dressing suppository matrix is prepared by taking gelatin, glycerol, polyethylene glycol derivatives and chitosan quaternary ammonium salt as raw materials, the biocompatibility of the suppository matrix is good, and stimulation and anaphylactic reaction cannot be generated on a medication cavity; and after the suppository matrix is dissolved in the cavity, a film with good adhesion can be formed on the mucous membrane of the cavity, so that the released medicine is fully contacted with the focus for a long time, the curative effect and bioavailability of the medicine are improved, and the suppository is suitable for preparing suppositories for treating gynecological diseases, anorectal diseases and prostate diseases.
Owner:ANHUI HUIKE BIO ENG TECH

Analysis kit and detection method of prostate small body leaked protein

The invention provides an analysis kit and a detection method of prostate small body leaked protein, and relates to the technical field of kits.The analysis kit comprises a kit body, a heating cavity is formed in the portion, adjacent to the lower portion of a storage groove, in the kit body, and an electric heating piece is fixedly installed on the top face of the inner end of the heating cavity; the microcontroller synchronously starts the failure judgment timing module, if the detection articles are not used within one hour, the module feeds back a signal to enable the microcontroller to control the micro motor to lock the box cover again, and the electric heating sheet in the heating cavity of the box body is started to forcibly discard the reagent, so that the detection error caused by the active failure reagent is prevented; according to the present invention, the accurate detection is ensured through the preparation before the detection and the reagent aging control, and the problems that the accuracy of the detection result is affected due to the lack of the temperature balance control mechanism and the reagent aging control function of the current prostate small body leakage protein detection kit so as to interfere the prostate disease clinical diagnosis and illness state evaluation are solved.
Owner:ONCO BIOMEDICAL TECH SUZHOU

Prostate disease ultrasonic treatment device

PendingCN119113433AAvoid low temperature burnspromote circulationUltrasound therapyDrive shaftUltrasound probe
The invention discloses a prostate disease ultrasonic treatment device, and relates to the technical field of ultrasonic treatment, the prostate disease ultrasonic treatment device comprises a host and a housing, one side of the host is provided with a moving rail, the guide rail is slidably connected with a support, and an ultrasonic probe is arranged below the support; the housing is arranged below the support, an intermittent assembly is arranged in an inner cavity of the housing, and a driving assembly is connected below the intermittent assembly; the intermittent assembly comprises a driving shaft, the driving shaft is arranged in the housing below the support, the outer surface of the driving shaft is fixedly connected with a first gear, and one side of the first gear is meshed with a rack used for intermittently driving the first gear to intermittently rotate in a reciprocating mode; the driving assembly comprises a second gear, and the second gear is arranged at the end, away from the support, of the driving shaft and used for driving the ultrasonic probe to rotate intermittently. The ultrasonic probe is driven to rotate in a reciprocating mode through the intermittent assembly, low-temperature scalding caused by the fact that the ultrasonic probe stays at a focus position for a long time is avoided, uniform energy distribution can stimulate tissues at different positions, and blood circulation and metabolism are promoted.
Owner:NINGBO ZHENHAI DISTRICT LONGSAI MEDICAL GRP

Composition for preventing, improving, or treating prostate disease, comprising hemp seed oil

The present invention provides a composition for improving, preventing, or treating prostate disease, comprising hemp seed oil as an active ingredient. A functional composition comprising hemp seed oil as an active ingredient, according to the present invention, reduces the prostate weight of benign prostatic hyperplasia patients, reduces blood prostate-specific antigen (PSA), dihydrotestosterone (DHT), and 5-alpha reductase I levels, and also has excellent cell growth inhibitory ability with respect to prostate cancer cells. Thus, the functional composition comprising hemp seed oil as an active ingredient, according to the present invention, is expected to be capable of exhibiting a preventive, relieving, or therapeutic effect on prostate disease including benign prostatic hyperplasia and prostate cancer.
Owner:KT&G CO LTD

Preparation and application of magnetic silica gel health-care material

The invention relates to the technical field of health care, in particular to preparation and application of a magnetic silica gel health care material, and the magnetic silica gel health care material sequentially comprises a magnetic conductive layer, a silica gel magnetic material layer and a magnetic shielding coating layer from inside to outside. Wherein the silica gel magnetic material layer is composed of a magnetic material, microporous silica gel, a traditional Chinese medicine extract, iron silicide, graphene and calamine, can generate a magnetic field and has a health-care function; the magnetic conductive layer is composed of a hydrogel-graphene composite material, a magnetic field can be enhanced according to acupuncture points, and the treatment and health care effects are improved; the magnetic shielding coating layer contains magnetic shielding filler and can prevent an external magnetic field from weakening or disappearing the magnetism of the magnetic material. The invention further provides a preparation method of the magnetic silica gel health-care material. The prepared magnetic silica gel health-care material is high in magnetism, good in health-care effect and good in skin-friendly performance of a human body, has permanent magnetism and is not prone to demagnetization. The magnetic silica gel health-care material can be applied to treatment of alopecia, backache, prostate diseases and the like.
Owner:郭锡俊

Mesenchymal stem cell composition for treating prostate diseases as well as preparation method and application of mesenchymal stem cell composition

The invention relates to the technical field of stem cell medicines, in particular to a mesenchymal stem cell composition for treating prostate diseases as well as a preparation method and application of the mesenchymal stem cell composition. The mesenchymal stem cell composition for treating the prostate diseases, disclosed by the invention, is prepared from mesenchymal stem cells subjected to hypoxia treatment and an anti-inflammatory peptide WYPWMKKHRRRRRRRR. The prostate diseases are selected from prostatitis, prostate calcification, sexual function improvement, frequent micturition, urgent micturition and the like. The mesenchymal stem cell composition disclosed by the invention can be used for remarkably improving symptoms of prostate diseases and is remarkable in curative effect.
Owner:广州飞来爱生命科技有限公司

A magnetic resonance treatment head for drug introduction into male prostate diseases

The present invention provides a drug introduction magnetic vibration treatment head for male prostate diseases, which effectively improves the cure rate of magnetic vibration treatment of male prostate diseases. The present invention comprises a support frame and a magnetic vibration treatment device fixedly installed at the front end of the support frame. The first drug introduction component comprises a fixed end head and a sliding end cover slidably installed on the front side of the fixed end head. A medicine ointment storage groove is provided at the rear end of the sliding end cover. A ring plate is fixedly connected to the front side of the fixed end head and slidably installed in the medicine ointment storage groove. A plurality of medicine outlet holes connected to the inner side of the sliding end cover are provided at the bottom of the ointment storage groove. A plurality of arc holes are penetrated from front to back on the sliding end cover. The present invention has a novel structure, an ingenious conception, and is simple and convenient to operate, and effectively achieves the purpose of fixing and adjusting the angle of the magnetic vibration treatment head.
Owner:ZHENGZHOU RENHUI MEDICAL EQUIP

Medicinal liquor special for treating prostate diseases and preparation method thereof

The invention relates to the technical field of medicinal liquor, in particular to medicinal liquor special for treating prostate diseases. 420g to 500g of Chinese yam; 420 g to 500 g of prepared rehmannia root; 420g to 500g of semen euryales; the weight of the cornus officinalis is 450 to 500 grams; 150 g to 180 g of syngnathus; 390-450 g of lotus seeds; and 5000-5500 g of sorghum liquor with the alcohol content of 62%. The medicinal liquor contains effective components of Chinese yam, gordon euryale seed, dogwood, lotus seed, syngnathus and stir-fried Chinese chive seed, 62-degree kaoliang spirit is selected as a solvent, the alcoholic strength is moderate, the effective components in the medicinal materials are fully extracted, the medicinal liquor has a remarkable treatment effect, and related symptoms of prostate diseases can be effectively relieved; after the medicinal liquor is prepared, a patient only needs to take the medicinal liquor according to the specified taking time and dosage, complicated operation or additional treatment equipment is not needed, and the medicinal liquor is suitable for patients with various types of prostate diseases, including prostatitis, prostatic hyperplasia and the like, has a wide application prospect, and has a cure effect of 100%.
Owner:石剑峰

Endurance sports nutritious food

The invention belongs to the technical field of food, and discloses endurance sports nutritious food, which is characterized by being prepared from the following raw materials by weight: 3g of raspberry, 1g of fructus lycii, 1g of fructus alpiniae oxyphyllae, 0.1 mg of vitamin B1, 0.1 mg of vitamin B2, 1mg of vitamin E, 0.5 mg of zinc, 0.05 g of stevia rebaudiana, and 0.01 g of edible essence. The traditional Chinese medicine has the effects of tonifying kidney, nourishing blood, protecting ovary and regulating menstruation. The traditional Chinese medicine composition can protect testis, prevent sexual hypofunction and prostate diseases, delay senescence, blacken hair and treat amnesia, tinnitus and hypopsia. And enuresis and dripping are carried out.
Owner:李炳茂

Prostate treatment device (QLX01)

1. The name of the product under this design: Prostate therapeutic device (QLX01). 2. Purpose of the product of this design: an auxiliary treatment instrument for male prostate diseases. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.
Owner:SHENZHEN YOUMAI INVESTMENT DEVELOPMENT CO LTD

Preparation process and application of a compound preparation of astaxanthin, lycopene and proanthocyanidins for anti-aging and preventing prostate diseases

The present invention discloses a preparation process and application of a compound preparation of astaxanthin, lycopene and proanthocyanidins for anti-aging and prevention of prostate diseases, belonging to the field of biomedicine. The preparation is composed of astaxanthin (1-10 parts), proanthocyanidins (5-30 parts), lycopene (2-15 parts), black cumin seed oil (0.5-3 parts), Phyllanthus emblica extract (3-8 parts) and Withania somnifera extract (1-5 parts), and is prepared by high-efficiency wet granulation technology. The components act synergistically to significantly enhance antioxidant, anti-inflammatory and anti-cancer activities, and have dual effects of anti-aging and prevention and treatment of prostate diseases. Experiments show that the hydroxyl radical scavenging rate of the compound preparation is 2.3 times higher than that of the single ingredient, the inflammatory factors in the prostatitis model are reduced by 68%, the skin antioxidant capacity is increased by 55%, and the combination with finasteride can reduce the dosage of chemical drugs by 80% and reduce the risk of sexual dysfunction. Black cumin seed oil significantly improves the bioavailability of lycopene (29.7%), and the drug concentration in the prostate tissue reaches 6.5 times that in the blood, achieving high efficiency with low dosage.
Owner:恢春丹生物科技(海南)有限公司

Pharmaceutical composition for treating prostate diseases and glandular nodules and application thereof

The invention belongs to the technical field of preparation and application of small molecule drugs, and particularly relates to a pharmaceutical composition for treating prostate diseases and glandular nodules and application of the pharmaceutical composition. The pharmaceutical composition comprises a heterocyclic compound with the structure shown in the formula I or pharmaceutically acceptable salt and a pharmaceutically acceptable carrier of the heterocyclic compound; # imgabs0 # wherein at least one of X1, X2, X3 and X4 is a nitrogen atom, and the remainder is a carbon atom; x5 is an oxygen atom or a carbon atom; and X6 is a nitrogen atom or a carbon atom.
Owner:SHANGHAI TIANLONG BIOTECH CO LTD

Single magnetic microsphere analysis method based on single particle inductively coupled plasma mass spectrometry

The purpose of this invention is to establish a single-particle inductively coupled plasma mass spectrometry (ICP-MS) method for analyzing single magnetic microspheres, which can effectively avoid signal fluctuations caused by errors during absolute quantification, achieving stable and accurate quantification of two prostate cancer biomarkers. The principle of this invention is: using... + Fe 58 The frequency signals of isotopes are used to unify the number of magnetic microspheres, and the results are obtained by evaluating the frequency signals of individual magnetic microspheres. + Au 197 and + Pt 194 The intensity distribution, calculated through average intensity or fitted intensity, yields stable analytical results unaffected by changes in the number of magnetic microspheres detected. This is achieved using the intensity distribution on a single magnetic microsphere. + Au 197 and + Pt 194 The linear relationship between intensity and tPSA and fPSA demonstrates that this analytical method enables the simultaneous detection of two prostate cancer biomarkers and can be applied to the simultaneous analysis of the concentrations of the two biomarkers in the serum of patients with prostate disease.
Owner:SICHUAN UNIV

Prostate tumor onset risk prediction method and system

The invention relates to the technical field of urinary system disease diagnosis, in particular to a prostate tumor onset risk prediction method and system. By combining multiple groups of indexes and image group feature data, the prostate diseases, especially the prostate tumors, can be effectively evaluated, score data reflecting the state of the prostate tumors can be obtained, and the incidence probability and the staging result degree of the endometrial diseases can be more intuitively determined through the score data. Therefore, the overall automatic prediction of the prostate disease is realized.
Owner:XINJIANG UYGUR AUTONOMOUS REGION OCCUPATIONAL DISEASE HOSPITAL (XINJIANG UYGUR AUTONOMOUS REGION OCCUPATIONAL DISEASE PREVENTION & CONTROL HOSPITAL)

Prostate transrectal ultrasound image automatic segmentation method, device, equipment and medium

The invention discloses an automatic segmentation method for a prostate transrectal ultrasound image, and relates to the technical field of machine learning, and the method comprises the following steps: S201, obtaining a prostate transrectal ultrasound image set of a patient; s202, creating a machine learning model for segmenting the prostate transrectal ultrasound image; s203, the obtained prostate transrectal ultrasound image set is preprocessed; s204, the machine learning model is used for automatically segmenting the preprocessed prostate transrectal ultrasound image set, and the prostate area is determined. The prostate image segmentation process is completely obtained through autonomous learning of the machine learning model, and a doctor with rich experience does not need to manually segment the prostate image; according to the prostate image segmentation method and device, the dependence on the professional level of a doctor is reduced, the burden of the doctor on diagnosing prostate diseases is greatly reduced, meanwhile, manual calibration can be carried out on the automatically segmented prostate image, the calibrated prostate image serves as an image sample to be stored in a database, and the accuracy of prostate image segmentation is further improved.
Owner:NANTONG INST OF TECH

Traditional Chinese medicine composition for benign prostatic hyperplasia, extract and application

The traditional Chinese medicine composition is prepared from the following raw materials: astragalus membranaceus, herba artemisiae anomalae, pollen typhae, rhizoma dioscoreae septemlobae, stiff silkworm, kelp, cinnamon, curcuma zedoary, euphorbia helioscopia, tortoise plastron and liquorice. According to the traditional Chinese medicine composition or the extract of the traditional Chinese medicine composition provided by the invention, under the guidance of a new thought of prostate meridian and collateral qi and blood differentiation, inherent physiological differences of different regions of the prostate are fully considered, pathological characteristics and pathogenesis of diseases are discriminated on the basis, and a new traditional Chinese medicine formula aiming at prostate lesions is constructed and formed; the traditional Chinese medicine formula especially aims at benign prostatic hyperplasia lesions.
Owner:DONGZHIMEN HOSPITAL OF BEIJING UNIV OF CHINESE MEDICINE

Umbilical cord mesenchymal stem cell preparation and application thereof in prostate disease treatment

PendingCN121949553AIncrease the amount of enrichmentReduce holdupAntipyreticAnalgesicsDiseaseAntiendomysial antibodies
The invention discloses a bispecific antibody-UC-MSCs preparation for targeting prostate diseases as well as preparation and application of the bispecific antibody-UC-MSCs preparation. The preparation comprises a bispecific antibody BsAb-1 and human umbilical cord mesenchymal stem cells (UC-MSCs), the BsAb-1 is formed by connecting an anti-CD105 single-domain antibody, an anti-PSCA single-domain antibody and a flexible peptide linker in series, wherein the amino acid sequence of the BsAb-1 is as shown in SEQ ID NO: 4. According to the preparation, the UC-MSCs are delivered to a prostate focus through the targeting bridge effect of BsAb-1, the focus enrichment amount within 72 hours is increased by 6.3 times compared with that of pure UC-MSCs, and meanwhile retention of non-target organs such as the liver and the spleen is reduced. The preparation can effectively relieve inflammatory response and fibrosis of chronic prostatitis, and the curative effect of the preparation is remarkably superior to that of pure UC-MSCs treatment. Precise targeted treatment of prostate diseases is achieved, the curative effect is remarkably better than that of a traditional stem cell therapy method, and high clinical application value is achieved.
Owner:GUANGZHOU SHIXING BIOMEDICAL TECHNOLOGY CO LTD